The Future of Childhood Cancer Survivorship : Challenges and Opportunities for Continued Progress
(2020) In Pediatric Clinics of North America 67(6). p.1237-1251- Abstract
As treatment evolves and the population who survive childhood cancer ages and increases in number, researchers must use novel approaches to prevent, identify and mitigate adverse effects of treatment. Future priorities include collaborative efforts to pool large cohort data to improve detection of late effects, identify late effects of novel therapies, and determine the contribution of genetic factors along with physiologic and accelerated aging among survivors. This knowledge should translate to individual risk prediction and prevention strategies. Finally, we must utilize health services research and implementation science to improve adoption of survivorship care recommendations outside of specialized pediatric oncology centers.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/1b873e6a-c66d-4c32-8273-407306ff362d
- author
- Dixon, Stephanie B. ; Chow, Eric J. ; Hjorth, Lars LU ; Hudson, Melissa M. ; Kremer, Leontien C.M. ; Morton, Lindsay M. ; Nathan, Paul C. ; Ness, Kirsten K. ; Oeffinger, Kevin C. and Armstrong, Gregory T.
- organization
- publishing date
- 2020
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Adolescent, Cancer, Child, Delivery of health care, Neoplasms, Survivor, Treatment outcome
- in
- Pediatric Clinics of North America
- volume
- 67
- issue
- 6
- pages
- 15 pages
- publisher
- W.B. Saunders
- external identifiers
-
- pmid:33131544
- scopus:85094202228
- ISSN
- 0031-3955
- DOI
- 10.1016/j.pcl.2020.07.013
- language
- English
- LU publication?
- yes
- id
- 1b873e6a-c66d-4c32-8273-407306ff362d
- date added to LUP
- 2020-11-04 14:40:10
- date last changed
- 2024-04-03 15:38:51
@article{1b873e6a-c66d-4c32-8273-407306ff362d, abstract = {{<p>As treatment evolves and the population who survive childhood cancer ages and increases in number, researchers must use novel approaches to prevent, identify and mitigate adverse effects of treatment. Future priorities include collaborative efforts to pool large cohort data to improve detection of late effects, identify late effects of novel therapies, and determine the contribution of genetic factors along with physiologic and accelerated aging among survivors. This knowledge should translate to individual risk prediction and prevention strategies. Finally, we must utilize health services research and implementation science to improve adoption of survivorship care recommendations outside of specialized pediatric oncology centers.</p>}}, author = {{Dixon, Stephanie B. and Chow, Eric J. and Hjorth, Lars and Hudson, Melissa M. and Kremer, Leontien C.M. and Morton, Lindsay M. and Nathan, Paul C. and Ness, Kirsten K. and Oeffinger, Kevin C. and Armstrong, Gregory T.}}, issn = {{0031-3955}}, keywords = {{Adolescent; Cancer; Child; Delivery of health care; Neoplasms; Survivor; Treatment outcome}}, language = {{eng}}, number = {{6}}, pages = {{1237--1251}}, publisher = {{W.B. Saunders}}, series = {{Pediatric Clinics of North America}}, title = {{The Future of Childhood Cancer Survivorship : Challenges and Opportunities for Continued Progress}}, url = {{http://dx.doi.org/10.1016/j.pcl.2020.07.013}}, doi = {{10.1016/j.pcl.2020.07.013}}, volume = {{67}}, year = {{2020}}, }